In a dimly lit lab at Helmholtz Munich, a hormone once known only for its role in metabolism is revealing a surprising new identity. FGF21, long studied for its effects on blood sugar and fat regulation, has now been shown to help cells survive internal chaos by boosting their defenses against misfolded proteins—a discovery that could reshape how we think about cellular resilience in disease. This isn’t just a metabolic messenger; it’s a guardian of cellular order.
Properly folded proteins are essential for life. When the process goes wrong—often under metabolic stress—cells activate emergency systems like the Unfolded Protein Response (UPR) and the Integrated Stress Response (ISR) to restore balance. Left unchecked, protein misfolding can lead to liver disease, diabetes, and neurodegenerative disorders. Now, research led by Prof. Timo D. Müller and Dr. Gerald Grandl at Helmholtz Munich and Ludwig Maximilians University reveals that FGF21 doesn’t just respond to metabolic signals—it directly strengthens these critical stress defenses.
The team discovered that FGF21 enhances sulfide signaling, a little-known but powerful pathway involved in cellular protection. By analyzing the molecular environment of the FGF21 receptor β-klotho, they found the hormone sits at the crossroads of protein folding and stress response. Most strikingly, FGF21 ramps up the activity of enzymes that produce hydrogen sulfide, a molecule increasingly recognized for its role in cell survival. When the researchers blocked sulfide production, FGF21’s protective effect vanished. Conversely, a hydrogen sulfide-releasing compound mimicked FGF21’s action—confirming the central role of sulfide signaling.
This mechanism was observed across multiple models: in cultured cells, mouse liver tissue, and live animals. Crucially, FGF21’s influence depended entirely on the presence of the β-klotho receptor—without it, the hormone had no effect on stress response. These findings, published in Cell Metabolism (2026), suggest FGF21 acts not as a trigger but as a force multiplier, amplifying the cell’s natural defenses only when under duress.
While the study is preclinical, its implications are tangible. FGF21 has long been a target of interest for metabolic liver diseases like NASH, where protein-folding stress plays a key role. Now, scientists have a clearer mechanistic roadmap: boosting FGF21 may help cells endure stress not just by improving metabolism, but by fortifying their internal quality-control systems. As Müller notes, this doesn’t offer an immediate cure—but it sharpens the tools for future therapies. In the quiet machinery of the cell, a new ally has emerged, not by taking charge, but by helping the body defend itself more effectively.